The value of diverse patient representation and engagement in cancer treatment To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in Share X The value of diverse patient representation and engagement in cancer treatment https://pharmaphorum.com/whitepapers/value-of-diverse-patient-representation-and-engagement-cancer/
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of Share X At ESMO, three studies show promise of antibody-drug conjugates in breast cancer https://pharmaphorum.com/oncology/esmo-three-studies-show-promise-antibody-drug-conjugates-breast-cancer/
Understanding the microbiome as an ‘overlooked critical organ’ Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there Share X Understanding the microbiome as an ‘overlooked critical organ’ https://pharmaphorum.com/r-d/understanding-the-microbiome-as-an-overlooked-critical-organ/
CRISPR therapies targeting the next breakthrough in oncology The potential of CRISPR technology has been a hot topic in the industry ever since it was first Share X CRISPR therapies targeting the next breakthrough in oncology https://pharmaphorum.com/r-d/crispr-therapies-targeting-the-next-breakthrough-in-oncology/
Cancer vaccines: providing the edge in oncology In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may Share X Cancer vaccines: providing the edge in oncology https://pharmaphorum.com/oncology/cancer-vaccines-providing-the-edge-in-oncology/
Putting patient perspectives at the heart of kidney cancer research Commissioned by Ipsen. Ipsen’s Steven Hildemann looks at how we can harness the power of patient perspectives in Share X Putting patient perspectives at the heart of kidney cancer research https://pharmaphorum.com/patients/patient-perspectives-kidney-cancer-research/
AI providing the edge against cancer? The global R&D pipeline is dominated by potential treatments in oncology and this is also where the investment Share X AI providing the edge against cancer? https://pharmaphorum.com/oncology/ai-providing-edge-against-cancer/
Regulation optimisation could save thousands of life years Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across Share X Regulation optimisation could save thousands of life years https://pharmaphorum.com/oncology/regulation-optimisation-save-thousands-life-years/
Merck on trends in oncology: the pharmaphorum podcast Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change Share X Merck on trends in oncology: the pharmaphorum podcast https://pharmaphorum.com/video/merck-on-trends-in-oncology/
